Breadcrumb Home Cancer Target Accelerator Develop efficient, systematic strategies for functional mapping of mutations to underlying biology to accelerate target evaluation and vetting: a “Target Accelerator.” Latest news News 11.03.2025 Biology of Adversity Project launches at ӳý News 10.31.2025 Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the ӳý for chimeric antigen receptor (CAR) T-cell therapy News 10.31.2025 Genetic variant increases risk of heart muscle disease common in individuals of African ancestry News 10.16.2025 ӳý-Bayer collaboration leads to drug candidate for a hard-to-treat type of lung cancer All news
News 10.31.2025 Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the ӳý for chimeric antigen receptor (CAR) T-cell therapy
News 10.31.2025 Genetic variant increases risk of heart muscle disease common in individuals of African ancestry
News 10.16.2025 ӳý-Bayer collaboration leads to drug candidate for a hard-to-treat type of lung cancer